| View Larger Image | Anticancer Therapeutics | Hardcoverby Sotiris Missailidis (Author)
| List Price: | $170.00 | | Price: | $143.61 | | You Save: | $26.39 (16%) | | | Available: | Usually ships in 24 hours |
| | Binding: | Hardcover | | Publisher: | Wiley | | Edition: | 1st Edition | | Page Count: | 424 Pages | | Publication Date: | December 31, 2008 | | Sales Rank: | 1,196,783st |
|
EDITORIAL REVIEWS |
Product Description
Written by the winner of the 2008 Mike Price Fellowship "This volume provides a comprehensive overview of the wealth of information now available in this important and fast-moving subject." Anticancer Research, November - December 2008 This book provides a clear introduction to the area, with an overview of the various drug design and development approaches for cancer therapeutics and their progress in today’s multidisciplinary approach to cancer treatment. Clearly structured throughout, the book not only provides information on currently used molecular treatment approaches, but also describes the various agents that are currently at various stages of development and clinical trials, thus making them the drugs of tomorrow. The book goes on to present current therapeutic regimes including their indications and side effects, as well as their position in the international market in terms of sales and development costs. Furthermore, coverage of our advancement in the understanding of cancer biology and how this has driven the drug discovery process is clearly discussed. Modern drug discovery aspects, through genomic, proteomic and metabolomic approaches are referred to as well as combinatorial chemistry techniques and discovery of chemotherapeutic agents from plant extracts, re-use of old drugs and drugs from other indications, or de novo rational drug design. Including contributions from leading experts in the field, this book provides the reader with a complete overview of the various types of therapeutic agents, current and emerging, as well as other aspects associated with anticancer therapy, drug design, resistance and clinical trials in oncology. |
SIMILAR PRODUCTS |
| Handbook of Cell-Penetrating Peptides, Second Edition
by Ulo Langel (Editor)
Since the first Handbook of Cell-Penetrating Peptides was prepared in 2001, the wealth of new information on the use of these peptides as transport systems has in fact served to confound the field. The constant internal change in the field of cell-penetrating peptides (CPPs) is due to recent research uncovering apparent ambiguities in cellular uptake. There is still neither a common terminology nor a uniform explanation for the penetrative mechanism of cell-penetrating peptides.
In this...
| 
| IMMUNOBIOLOGY 7 PB (Janeway's Immunobiology) (Immunobiology: The Immune System (Janeway))
by Kenneth M. Murphy (Author), Paul Travers (Author), Mark Walport (Author)
Janeway's Immunobiology, Seventh Edition is an introductory text for use in immunology courses for undergraduates, graduate students and medical students. It guides the reader through the immune system in all its aspects - from the first engagement of innate immunity to the generation of the adaptive immune response and its clinical consequences. The Seventh Edition has been comprehensively updated throughout, and includes new information on topics such as NK cells, Toll-like receptors, AID,...
|
|
|
